Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Clinical trial NCT03144999 · COMPLETED

Trial details

NCT number: NCT03144999
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dry Age-related Macular Degeneration

Start date: 2017-03-29
Primary completion: 2017-12-06
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.